The HOMEZ Knockout A-549 Polyclonal Cells product is a targeted loss-of-function model generated by CRISPR/Cas9-mediated disruption of the HOMEZ gene in A-549 human lung adenocarcinoma cells. This polyclonal knockout cell population consists of a heterogeneous mixture of edited cells, each carrying distinct modifications at the HOMEZ locus, providing a powerful tool for studying the collective impact of HOMEZ gene disruption without clonal selection. The use of CRISPR/Cas9 technology enables efficient and precise introduction of genetic lesions, making this model suitable for functional genomics, pathway analysis, and drug target validation studies.
The host cell line, A-549, is a well-established human lung adenocarcinoma epithelial cell line originally derived from a 58-year-old male patient. A-549 cells retain key features of alveolar type II pneumocytes and are widely employed in respiratory disease research, particularly for investigating lung cancer biology, epithelial barrier function, and responses to therapeutic agents. Their robust growth characteristics and well-characterized signaling networks make them an ideal platform for studying the molecular mechanisms underlying non-small cell lung carcinoma (NSCLC) pathogenesis.
HOMEZ encodes a homeobox- and zinc finger-containing transcription factor that integrates extracellular signals to regulate gene expression programs governing cell proliferation, differentiation, and possibly embryonic development. It functions downstream of the Wnt signaling pathway, where Wnt ligands such as WNT3A engage Frizzled receptors to stabilize ??-catenin, which then partners with TCF/LEF transcription factors to activate target genes. HOMEZ is thought to associate with PBX and MEIS family cofactors, forming higher-order transcriptional complexes that modulate downstream effectors involved in cell cycle control and lineage commitment. Additionally, crosstalk with Notch signaling may further refine its regulatory output, positioning HOMEZ at a convergence point of multiple developmental signals.
In the context of A-549 lung adenocarcinoma cells, loss of HOMEZ function is expected to perturb transcriptional networks that sustain the malignant phenotype, potentially impacting proliferation, survival, and metastatic capacity. This polyclonal knockout model allows researchers to assess how HOMEZ disruption alters cellular behavior without the confounding effects of clonal adaptation, thereby better reflecting the heterogeneity of gene editing outcomes. It provides a physiologically relevant system to explore the role of homeobox transcription factors in NSCLC, including their influence on tumor-initiating cell properties and responsiveness to conventional chemotherapies or targeted agents.
Typical experimental applications include transcriptomic profiling via RNA-seq to identify HOMEZ-dependent gene signatures, functional assays such as proliferation, apoptosis, and migration analyses, and mechanistic studies using chromatin immunoprecipitation or co-immunoprecipitation to map protein?CDNA and protein?Cprotein interactions. Moreover, this model is well-suited for drug resistance investigations, where HOMEZ loss may sensitize or desensitize cells to specific inhibitors, and for high-throughput screening of small molecules targeting downstream pathways. For detailed protocols, pricing, or technical support, interested parties are encouraged to contact Ascent Research.
